Ian Karp

Investor Relations Contact chez COLLEGIUM PHARMACEUTICAL, INC.

Health Technology

Consumer Services

Profil

Ian Karp is currently Head-Investor Relations at Collegium Pharmaceutical, Inc. Former positions include Senior Director-Global Marketing at MedImmune LLC, Vice President & Head-Investor Relations at Shire Plc from 2016 to 2017, Senior Vice President-Investor & Public Relations at Karyopharm Therapeutics, Inc., and Senior Vice President-Corporate Communications at Intellia Therapeutics, Inc. Education includes an undergraduate degree from Emory University and an MBA from Rutgers Business School.

Postes actifs de Ian Karp

Sociétés	Poste	Début
COLLEGIUM PHARMACEUTICAL, INC.	Investor Relations Contact	-

Tous les postes actifs de Ian Karp

Anciens postes connus de Ian Karp

Sociétés	Poste	Fin
SHIRE	Investor Relations Contact	01/12/2017
INTELLIA THERAPEUTICS, INC.	Public Communications Contact	-
MedImmune LLC MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company	Sales & Marketing	-
KARYOPHARM THERAPEUTICS INC.	Investor Relations Contact	-

Voir l'expérience en détail de Ian Karp

Formation de Ian Karp

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Ian Karp

Relations

Relations au 1er degré

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées	7
MedImmune LLC MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company	Health Technology
Collegium Pharmaceutical, Inc. Collegium Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products	Health Technology
Shire Plc Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases	Health Technology
Emory University Emory University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Karyopharm Therapeutics, Inc. Karyopharm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel drugs for the treatment of cancer, inflammation and other diseases related to cell proliferation	Health Technology
Rutgers Business School Rutgers Business School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Intellia Therapeutics, Inc. Intellia Therapeutics, Inc. BiotechnologyHealth Technology Develops novel and potentially curative therapeutics	Health Technology